Serum osteoprotegerin and renal function in the general population: the Tromsø Study.

Journal: Clinical kidney journal
Published Date: Oct 3, 2016

Abstract

BACKGROUND: Serum osteoprotegerin (OPG) is elevated in patients with chronic kidney disease (CKD) and increases with decreasing renal function. However, there are limited data regarding the association between OPG and renal function in the general population. The aim of the present study was to explore the relation between serum OPG and renal function in subjects recruited from the general population.

Authors

  • Anders Vik
    K.G. Jebsen - Thrombosis Research and Expertise Center, Department of Clinical Medicine, UiT - The Arctic University of Norway, 9037 Tromsø, Norway.
  • Ellen E Brodin
    K.G. Jebsen - Thrombosis Research and Expertise Center, Department of Clinical Medicine, UiT - The Arctic University of Norway, 9037 Tromsø, Norway.
  • Ellisiv B Mathiesen
    K.G. Jebsen - Thrombosis Research and Expertise Center, Department of Clinical Medicine, UiT - The Arctic University of Norway, 9037 Tromsø, Norway.
  • Jan Brox
    K.G. Jebsen - Thrombosis Research and Expertise Center, Department of Clinical Medicine, UiT - The Arctic University of Norway, 9037 Tromsø, Norway.
  • Lone Jørgensen
    Department of Health and Care Sciences, UiT - The Arctic University of Norway, Norway.
  • Inger Njølstad
    K.G. Jebsen - Thrombosis Research and Expertise Center, Department of Clinical Medicine, UiT - The Arctic University of Norway, 9037 Tromsø, Norway.
  • Sigrid K Brækkan
    K.G. Jebsen - Thrombosis Research and Expertise Center, Department of Clinical Medicine, UiT - The Arctic University of Norway, 9037 Tromsø, Norway.
  • John-Bjarne Hansen
    K.G. Jebsen - Thrombosis Research and Expertise Center, Department of Clinical Medicine, UiT - The Arctic University of Norway, 9037 Tromsø, Norway.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals